Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Applications of functional neurotransmitter release imaging with genetically encoded sensors in psychiatric research
    Published on 2024-06-28
    2 years ago
  • VTA glutamatergic projections to the nucleus accumbens suppress psychostimulant-seeking behavior
    Published on 2024-06-26
    2 years ago
  • Ketamine reduces the neural distinction between self- and other-produced affective touch: a randomized double-blind placebo-controlled study
    Published on 2024-06-25
    2 years ago
  • Cross-ancestry genetic investigation of schizophrenia, cannabis use disorder, and tobacco smoking
    Published on 2024-06-21
    2 years ago
  • A review of diffusion MRI in mood disorders: mechanisms and predictors of treatment response
    Published on 2024-06-20
    2 years ago
  • Quality over quantity: powering neuroimaging samples in psychiatry
    Published on 2024-06-20
    2 years ago
  • Racial and ethnic socioenvironmental inequity and neuroimaging in psychiatry: a brief review of the past and recommendations for the future
    Published on 2024-06-20
    2 years ago
« Previous 1 … 85 86 87 88 89 … 143 Next »
Journal of Psychopharmacology
  • Clinical effects of glabellar botulinum toxin injections on borderline personality disorder: A randomized controlled trial
    Published on 2022-02-01
    4 years ago
  • Development and validation of the Reward Deficiency Syndrome Questionnaire (RDSQ-29)
    Published on 2022-02-01
    4 years ago
  • The neuropeptide cycloprolylglycine produces antidepressant-like effect and enhances BDNF gene expression in the mice cortex
    Published on 2022-02-01
    4 years ago
  • Comparative safety of chronic versus intermittent benzodiazepine prescribing in older adults: A population-based cohort study
    Published on 2022-02-01
    4 years ago
  • Modulation of microglial activation by antidepressants
    Published on 2022-01-29
    4 years ago
  • Refractory delirium tremens treated with ketamine
    Published on 2022-01-11
    5 years ago
  • A phase 1 study to assess potential interaction between ASP8062 and alcohol in healthy adult subjects
    Published on 2022-01-07
    5 years ago
« Previous 1 … 85 86 87 88 89 … 150 Next »
European Neuropsychopharmacology
  • Requiem or resurrection: Classic monoamine oxidase inhibitors revisited
    Published on 2022-06-14
    4 years ago
  • A double-blind, randomized, placebo-controlled proof of concept study of the efficacy and safety of Lu AF11167 for persistent negative symptoms in people with schizophrenia
    Published on 2022-06-12
    4 years ago
  • Digital tools for the assessment of pharmacological treatment for depressive disorder: State of the art
    Published on 2022-06-04
    4 years ago
  • A pacemaker for happiness – Transcutaneous vagus nerve stimulation in depression
    Published on 2022-06-03
    4 years ago
  • Expert consensus recommendations on the use of randomized clinical trials for drug approval in psychiatry- comparing trial designs
    Published on 2022-06-03
    4 years ago
  • Corrigendum to “34th ECNP Congress – Lisbon 2021 Hybrid. [34th ECNP Congress – Lisbon 2021 Hybrid. 53S1. December 2021]” P.0576 Knockdown of 5-HT1A receptor silencer Freud-2 in the frontal cortex affected the behavior and the serotonin system in mice
    Published on 2022-06-03
    4 years ago
  • Transcriptome meta-analysis of valproic acid exposure in human embryonic stem cells
    Published on 2022-05-28
    4 years ago
« Previous 1 … 85 86 87 88 89 … 168 Next »

   Pharma Pub